Moving Ahead with Intelligent Virtual Clinical Trials
Fuelled by the current COVID-19 pandemic and the considerable volume of data generated during a clinical trial, Artificial Intelligence (AI) has provided the much-needed impetus for transforming clinical trials into the virtual sphere for greater efficiency. From patient recruitment, protocol design, trial monitoring, to identifying the effect of blood thinners on virtual patients with irregular heartbeats, leveraging AI has helped life-saving drugs reach the market sooner.
To download and read our article, authored by Dr. Ayaaz Hussain Khan, Global Head of Generics, and published in PharmaFocus Asia, please complete the adjacent form.
Article published in PharmaFocus Asia | Issue 41 | 2020
© 2020 Navitas Life Sciences | Privacy Policy